AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23442582
Drug: MenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MenB vaccine Bexsero
Trial: 19845667
Drug: 4% niacinamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% niacinamide + 2% NAG in SPF 15 sunscreen moisturizing lotion and evening moisturizing cream (test formulation)
Trial: 19845667
Drug: Vehicle control
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle control (SPF 15 lotion and cream vehicles)
Trial: 16639484
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg/weekly + salazopyrin 2 g/daily
Trial: 16639484
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg/weekly + infliximab 3 mg/Kg at time 0, 2, 4 and every 8 weeks
Trial: 16639484
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg/weekly + etanercept 25 mg/twice weekly
Trial: 16639484
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg/weekly + adalimumab 40 mg/every other week
Trial: 11834533
Drug: Atorvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (20 mg per day for 4 months)
Trial: 9892883
Drug: Propantheline (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propantheline (15 mg)
Trial: 2076384
Drug: Pindolol (0.015
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (0.015 mg/kg intravenously)
Trial: 2076384
Drug: Atenolol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (0.1 mg/kg intravenously)
Trial: 2076384
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg/day orally)
Trial: 2076384
Drug: Pindolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (10 mg/day orally)
Trial: 2076384
Drug: Atenolol (intravenous)
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol (intravenous)
Trial: 2076384
Drug: Pindolol (intravenous)
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol (intravenous)
Trial: 2076384
Drug: Atenolol (oral)
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol (oral)
Trial: 2076384
Drug: Pindolol (oral)
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol (oral)
Trial: 7361794
Drug: Rectal thiopental
RxNorm normalized name: thiopental Rectal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal thiopental (25-45 mg/kg)
Trial: 7361794
Drug: Intramuscular cocktail
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular cocktail (2.0 mg/kg meperidine, 1.0 mg/kg chlorpromazine, 1.0 mg/kg promethazine)
Trial: 25579006
Drug: Superior joint
RxNorm normalized name: Astaxanthin/Hyaluronic Acid/Krill Oil Oral Capsule, Liquid Filled [MEGARED SUPERIOR JOINT CARE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Superior joint space injection of hyaluronic acid (HA)
Trial: 25579006
Drug: Inferior joint
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inferior joint space injection of hyaluronic acid (HA)
Trial: 24952864
Drug: ADRC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADRC treatment
Trial: 19164343
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg montelukast
Trial: 19164343
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of desloratadine and montelukast
Trial: 17907854
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for Adolescents with Depression Study (TADS)
Trial: 8549577
Drug: Continuous contractions
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous contractions (CC) - 30 seconds with 1-minute rest
Trial: 2108885
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg leuprorelin acetate depot
Trial: 2108885
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg leuprorelin acetate depot
Trial: 2108885
Drug: 3.75 mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg, 7.5 mg, and 15 mg leuprorelin acetate depot
Trial: 518076
Drug: Control (other
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (other antibiotics, n=30)
Trial: 30846896
Drug: IUD plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IUD plus a new crosslinked hyaluronan (NCH) gel
Trial: 30846896
Drug: NCH gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NCH gel only
Trial: 19843321
Drug: XanGo Juice
RxNorm normalized name: mango juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XanGo Juice 18 oz twice daily
Trial: 19843321
Drug: XanGo Juice
RxNorm normalized name: mango juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XanGo Juice 3 oz twice daily
Trial: 19843321
Drug: XanGo Juice
RxNorm normalized name: mango juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XanGo Juice 6 oz twice daily
Trial: 9032592
Drug: IPM/CS monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPM/CS monotherapy
Trial: 9032592
Drug: IPM/CS combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPM/CS combination therapy
Trial: 9032592
Drug: IPM/CS combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPM/CS combination therapy with other antibiotics (not penicillins, cephalosporins, or aminoglycosides)
Trial: 1523286
Drug: Diazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (15 or 20 mg orally)
Trial: 1523286
Drug: Lorazepam (1.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (1.75 or 2.5 mg orally)
Trial: 6498137
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of triamcinolone acetonide
Trial: 3946771
Drug: Hyoscine patch
RxNorm normalized name: HYOSCINE HYDROBROMIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine patch applied to the skin behind one ear
Trial: 3946771
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch applied to the skin behind one ear
Trial: 29620914
Drug: Metformin (500-850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500-850 mg given twice a day)
Trial: 29620914
Drug: Metformin (open-label
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (open-label from week 17 to week 32)
Trial: 20865841
Drug: LGP‐HA +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LGP‐HA + L (Lidocaine hydrochloride 2%)
Trial: 12656456
Drug: Toto ointment
RxNorm normalized name: Toto ni vavalagi oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toto ointment alone
Trial: 12656456
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Toto ointment and soap
Trial: 12656456
Drug: Sulfur ointment
RxNorm normalized name: sulfur Topical Ointment
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfur ointment alone
Trial: 6132220
Drug: Sealed catheters
RxNorm normalized name: GOLDEN SEAL
DrugBank: Goldenseal (DB16594)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sealed catheters among patients receiving systemic antibiotics
Trial: 6132220
Drug: Unsealed catheters
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unsealed catheters among patients receiving systemic antibiotics
Trial: 29690736
Drug: Analgesic and
RxNorm normalized name: otologic analgesic and anesthetic combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic and sedative treatment for 24 hours besides conventional treatment
Trial: 29690736
Drug: Analgesic and
RxNorm normalized name: otologic analgesic and anesthetic combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic and sedative treatment
Trial: 26890974
Drug: Decaffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated coffee plus 5 mg.kg anhydrous caffeine (D + C)
Trial: 26396949
Drug: Topical intranasal
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical intranasal corticosteroid
Trial: 20577273
Drug: Standard‐fluence verteporfin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard‐fluence verteporfin photodynamic therapy (PDT) + ranibizumab
Trial: 15704509
Drug: Home training
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home training with additional physical therapy
Trial: 15704509
Drug: Home training
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home training without additional physical therapy
Trial: 6386033
Drug: Zinc oxide
RxNorm normalized name: Zinc Oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc oxide treatment (400 micrograms ZnO/cm2)
Trial: 6386033
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (identical compress without zinc oxide)
Trial: 29610765
Drug: Test implant
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test implant (modified design intended to increase primary stability)
Trial: 29610765
Drug: Control implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control implant (standard design)
Trial: 20435966
Drug: Treatment by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment by experienced community psychotherapists
Trial: 18378545
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine (30 g/day)
Trial: 2217831
Drug: lipo-PGI2 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lipo-PGI2 (2 micrograms daily for one week)
Trial: 23508376
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) using green 532 nm diodes
Trial: 19621732
Drug: Triple-drug Hp
RxNorm normalized name: HP 502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug Hp eradication therapy (lansoprazole 30 mg bid, amoxicillin 1000 mg bid, clarithromycin 500 mg bid) for 2 weeks
Trial: 11368983
Drug: Levonorgestrel (LNG)
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levonorgestrel (LNG) 0.75 mg administered twice immediately before ovulation
Trial: 9412549
Drug: Inhaled albuterol
RxNorm normalized name: albuterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled albuterol (800 micrograms/day)
Trial: 7528360
Drug: Low-dose aprotinin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aprotinin (30,000 KIU/kg in the priming solution)
Trial: 3293777
Drug: Vitamin supplements
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin supplements (400 mg each of ascorbic acid and alpha-tocopherol)
Trial: 29072165
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care therapy for respiratory infection along with a single oral dose of 100,000 IU of vitamin D3
Trial: 29072165
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care therapy alone
Trial: 19737278
Drug: Super-selective intraprostatic
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Super-selective intraprostatic androgen deprivation therapy
Trial: 17175104
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg rofecoxib (selective COX-2 inhibitor)
Trial: 17175104
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg ketorolac (dual COX-1/COX-2 inhibitor)
Trial: 14996144
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 mg daily for up to 8 weeks
Trial: 7935234
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia (TIVA) with midazolam and fentanyl
Trial: 7935234
Drug: Inhalation anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anesthesia with thiamylal, enflurane, and nitrous oxide
Trial: 3341258
Drug: Full-fat acidified
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-fat acidified milk fortified with 15 mg of elemental Fe as ferrous sulfate and 100 mg of ascorbic acid/100 g of powder
Trial: 28025964
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of pregabalin 150-mg capsules
Trial: 28025964
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of pregabalin 150-mg capsules
Trial: 23080548
Drug: Sequential clomiphene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential clomiphene citrate/hMG regimen (CC/hMG)
Trial: 19271419
Drug: MgCl2 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MgCl2 5% solution (450 mg elemental magnesium)
Trial: 29132879
Drug: Rivaroxaban (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban (2.5 mg orally twice a day) plus Aspirin (100 mg once a day)
Trial: 29132879
Drug: Rivaroxaban (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban (5 mg orally twice a day)
Trial: 25845277
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg IV bolus at induction, followed by 0.25 mg/kg/h infusion until end of surgery)
Trial: 24117389
Drug: Placebo (initially)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (initially) then Ustekinumab 45 mg or 90 mg
Trial: 23561840
Drug: High-dose propofol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose propofol (3.2 μg/mL)
Trial: 23561840
Drug: Medium-dose propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medium-dose propofol (2.4 μg/mL)
Trial: 23561840
Drug: Low-dose propofol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose propofol (1.8 μg/mL)
Trial: 19092348
Drug: Celiac axis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiac axis infusion (CAI) and radiotherapy (RT) consisting of intra-arterial mitoxantrone, 5-FU, leucovorin, and cisplatinum in combination with 30 x 1.8 Gy radiotherapy (group A)
Trial: 19092348
Drug: Celiac axis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiac axis infusion (CAI) and radiotherapy (RT) for periampullary tumors
Trial: 19092348
Drug: Celiac axis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiac axis infusion (CAI) and radiotherapy (RT) for pancreatic cancer
Trial: 12500073
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 or 40 mg)
Trial: 12500073
Drug: Clomipramine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (75 or 150 mg)
Trial: 11303310
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of trometamol (TRIS, pH = 10.5) intravenously for 5 minutes, followed by deep breathing for 5 minutes at a rate of 40/min.
Trial: 8623998
Drug: Neostigmine 0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.06 mg.kg‐1
Trial: 8623998
Drug: Butyrylcholinesterase (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butyrylcholinesterase (25 ml.kg‐1 and 70 ml.kg‐1 of human plasma equivalent)
Trial: 3898847
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative intramuscular dose of cefoxitin (2 gm)
Trial: 3898847
Drug: Two or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two or three doses of cefoxitin (2 gm)
Trial: 1675315
Drug: 150 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg/day aspirin
Trial: 6447272
Drug: Mega-doses of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mega-doses of vitamin E
Trial: 24283222
Drug: First- and
RxNorm normalized name: hexylresorcinol
DrugBank: Hexylresorcinol (DB11254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First- and second-generation antipsychotics
Trial: 21338276
Drug: Tetradecylthioacetic acid
RxNorm normalized name: Tetradecylthioacetic acid
DrugBank: Tetradecylthioacetic acid (DB18802)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetradecylthioacetic acid (TTA) 1000 mg daily for 28 days
Trial: 17519543
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) given orally
Trial: 17519543
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) in vitro
Trial: 9529766
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen treatment (100% oxygen, pressure)
Trial: 31786934
Drug: Ketamine (0.71
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.71 mg/kg)
Trial: 30918134
Drug: Exenatide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (10 μg b.i.d.) for 12 weeks
Trial: 30918134
Drug: Metformin (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1,000 mg b.i.d.) for 12 weeks
Trial: 23887741
Drug: Levosimendan infusion
RxNorm normalized name: levosimendan
DrugBank: Levosimendan (DB00922)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan infusion at 0.1 μg/kg/min, every 30 days
Trial: 17121211
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg once a day
Trial: 10694193
Drug: L-arginine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (15 g/day)
Trial: 9017786
Drug: Pharmacologic agents
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic agents that reduce leukotriene activity or enhance prostaglandin activity, or agents that do both; specific agents not detailed.
Trial: 9017786
Drug: Beta-agonists and
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-agonists and cromolyn sodium; specific dosages and durations not mentioned.
Trial: 25100359
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone treatment for 36 months
Trial: 10533793
Drug: Interferon-alpha (IFNalpha)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFNalpha) treatment
Trial: 29780293
Drug: Granulocyte-colony stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Granulocyte-colony stimulating factor (G-CSF) followed by infusion of autologous mobilized peripheral blood mononuclear cells (mPBMCs)
Trial: 24655586
Drug: Hatha yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hatha yoga as add-on treatment
Trial: 24655586
Drug: Cortisol improvers
RxNorm normalized name: Improvest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol improvers in week 1 of therapy
Trial: 17546332
Drug: 200mg iron
RxNorm normalized name: polysaccharide iron complex 200 MG [EZFE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200mg iron sulfate alone (40 mg elemental iron) for 30 weeks
Trial: 15705659
Drug: 1-(13)C-labeled l-leucine
RxNorm normalized name: L-Leucine
DrugBank: Leucine (DB00149)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1-(13)C-labeled l-leucine infusion
Trial: 10088595
Drug: Two treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two treatments
Trial: 8848187
Drug: Bromocriptine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (15 mg daily)
Trial: 1970108
Drug: Autolymphocyte therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autolymphocyte therapy (ALT) plus oral cimetidine
Trial: 1970108
Drug: Autolymphocyte therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autolymphocyte therapy (ALT)
Trial: 7425360
Drug: Methohexital 20
RxNorm normalized name: methohexital 200 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methohexital 20 mg/kg, rectally